Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P02794 (ferritin)
 17,525 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In order to test the hypothesis that serum ferritin below 60 micrograms/l is a good indicator of iron deficiency in patients with rheumatoid arthritis peroral iron was given to 67 patients with active rheumatoid arthritis over a three month period. A rise in haemoglobin concentration was taken as evidence of iron responsive anaemia. In anaemic patients serum ferritin below 60 micrograms/l was a good indicator of iron responsive anaemia, with a predictive value of 83%. Although high plasma transferrin and low mean cell volume showed similar predictive values, more patients with iron deficiency anaemia could be diagnosed by serum ferritin measurements than by other conventional blood tests. In contrast, the predictive value of serum ferritin above 60 micrograms/l was low (50%). The test was of no predictive value in non-anaemic patients. In patients with anaemia and active rheumatoid arthritis serum ferritin is the best blood test currently available for the prediction of iron responsive anaemia.
 ...
PMID:Serum ferritin as indicator of iron responsive anaemia in patients with rheumatoid arthritis. 374 Sep 84

Traditionally the iron status of a population is assessed by estimating the prevalence of iron deficiency anemia. This approach is inadequate in countries where the diet is heavily fortified with iron because it conveys no information about the iron-replete segment of the population. In the present study iron status of a US adult population was evaluated using data collected in the second National Health and Nutrition Examination Survey (NHANES II). Body iron was estimated in each of 2,829 individuals from measurements of hemoglobin concentration, serum ferritin, transferrin saturation, and erythrocyte protoporphyrin. When individuals between 18 and 64 years of age were divided on the basis of sex and menstrual status, body iron reserves were normally distributed and averaged 309 mg in women 18 to 44 years, 608 mg in women 45 to 64 years, and 776 mg in men 18 to 64 years. The dispersion of storage iron in these groups was similar, with standard deviations of 346, 372, and 313 mg, respectively. The prevalence of iron deficiency anemia was surprisingly low, ranging from only 0.2% in adult men to 2.6% and 1.9% in pre- and postmenopausal women, respectively. Epidemiologic methods that examine iron status in the entire population assume importance in light of evidence that in certain segments of the US population, iron deficiency anemia is now less common than the homozygous state for hereditary hemochromatosis.
 ...
PMID:Estimates of iron sufficiency in the US population. 374 51

The effects of age and sex on haematological laboratory parameters were studied in connection with a population study in people over the age of 65 years (n = 347). Serum vitamin B12 was the only parameter which decreased significantly with advancing age. Blood leucocyte count, haemoglobin concentration, haematocrit, erythrocyte count, mean erythrocyte volume, mean erythrocyte haemoglobin and serum ferritin values were significantly higher in males than in females. Serum iron, serum transferrin, and plasma and erythrocyte folate levels did not differ between males and females. Thirteen subjects were anaemic and three of them had iron deficiency anaemia. Five subjects had iron deficiency based on serum iron and transferrin but no anaemia. Serum ferritin measurement did not reveal any further subjects with iron deficiency. No case of folate deficiency anaemia was revealed. Although many of the participants were on medication, most of them were living at home and taking care of themselves and represent relatively fit elderly people. Therefore we suggest that these laboratory data can also serve as reference values for the elderly people.
 ...
PMID:Haematological laboratory findings in the elderly: influence of age and sex. 374 86

We examined the iron nutritional status of healthy term infants in a longitudinal study from 15 through 365 days of age. All infants were fed according to the present austrian recommendations. Serum hemoglobin (Hb) decreased from 15 through 122 days of age and remained constant thereafter. At 365 days of age, only 4.7% of the infants had hemoglobin levels below 11 g/dl, which is considered the borderline value for anemia. Mean corpuscular volume (MCV) of erythrocytes was changing during infancy. Free erythrocyte protoporphyrin (FEP) was constant from 122 days through 365 days of age. The upper normal value of 3 micrograms/gHb for infants older than 122 days of age corresponded to that for children older than one year and adults. Serum ferritin (SF) decreased from 15 through 183 days of age and remained constant thereafter. At 365 days of age, only 9.3% of the infants had SF below 10 micrograms/l, which is considered the borderline concentration for depletion of iron stores. We found no differences of iron nutritional status between infants who were breastfed longer than 122 days and infants who were breastfed shorter than 122 days or were fed formula. Our findings indicate that the prevalence of iron deficiency anemia and depletion of the iron stores is lower than in previous studies. Changes in infant nutrition during the last years resulted in higher iron intake and lower prevalence of iron deficiency.
 ...
PMID:[Nutritional iron status of infants fed according to current recommendations]. 380 51

Of the 85 female marathon runners examined in this study, 14 (16%) had serum ferritin levels below 40 ng/ml but only two (2%) had iron deficiency anaemia (haemoglobin below 12 g/dl); 28 (33%) had serum folate levels below 4.8 ng/ml and of these two (2%) had haemoglobin levels below 12 g/dl and 13 (15%) had mean corpuscular volumes greater than 95 fl. One week after treatment with oral folate (5 mg/day) or iron (50 mg of elemental iron/day), serum ferritin and folate levels were normal but maximum oxygen uptake, maximum treadmill running time, peak blood lactate levels and the running speed at the blood 'lactate turnpoint' were not changed from values measured during an identical test performed 1 week earlier. These parameters were also unchanged in a third exercise test performed after a further 10 weeks of treatment. Serum folate or serum ferritin levels in a control (placebo-treated) group with initially high serum ferritin or folate levels fell with placebo treatment but maximum treadmill running time, maximum oxygen uptake values, peak blood lactate levels and the running speed at the blood 'lactate turnpoint' were unchanged. We conclude that biochemical evidence of iron and folate deficiency is relatively common in female distance runners; that 1 week of treatment corrects the biochemical evidence of folate and iron deficiency but that such treatment does not influence maximal exercise performance nor does it alter blood lactate levels during exercise. In the absence of iron deficiency anaemia, iron therapy for reduced serum ferritin levels, or folate therapy for low serum folate levels, may not improve maximal treadmill performance even in trained runners.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:The effect of iron and folate therapy on maximal exercise performance in female marathon runners with iron and folate deficiency. 382 89

The effects of the Steel Ring, the Copper V (VCu 200), and the Copper T (TCu 220c) were compared in terms of menstrual blood loss, serum ferritin, the incidence of menorrhagia, and anemia before and after insertion to evaluate the safety of these IUDs and to determine if any of them are appropriate for longterm use in Chinese women. 60 healthy women, 20-39 years, with regular menstrual periods, normal pelvic examination, who had used no oral contraceptives (OCs) for more than 1 year were recruited. Those who previously had used an IUD or had an abortion or parturition were admitted after at least 3 normal menses. Each subject was instructed in the method for complete collection of menstrual blood for 1 entire menstrual period. Menstrual blood loss was measured by alkaline hematin photometry and a Stomacher Lab-blender was used for extraction. The insertions of the IUDs were uneventful. After insertion, the mean blood loss for each group at all intervals was significantly higher than that of preinsertion, especially in the 1st postinsertion cycle. Thereafter, blood loss remained high or gradually decreased, but it did not return to the preinsertion levels even at the 24th postinsertion cycle. The differences were still significant, especially for the T group. The mean increase 25.4 ml (55.8%) for the Ring group, 32.3 ml (56.8%) for the V group, and 39.9 ml (82.2%) for the T group. The highest blood loss for the Ring group was 154 ml, for the V group 290.9 ml, and for the T group 211 ml. The incidence of menorrhagia of all IUDs was significantly increased in the 1st postinsertion cycle. Except for the Ring group, the differences were still significant even in the 24th postinsertion cycle. The mean value of serum ferritin for the Ring group was significantly decreased at the 18 and 24th postinsertion cycles. For the V group, the mean value decreased significantly at the 6, 12, and 18th postinsertion cycles and was below the normal level (16 ng/ml). For the T group, the mean value decreased significantly at the 12th and 18th postinsertion cycles, but the difference was not significant at the 24th postinsertion cycle as compared with preinsertion in either the V or T groups. After insertion, the mean hemoglobin (Hb) concentrations were still above 12 gm/dl in each cycle, but the incidence of Hb less than 12 gm/dl, which was zero before insertion in all groups, for the Ring group was 12.5% and 6.2% at the 12 and 24th postinsertion cycles and for the V group, 10% at the 1st postinsertion cycle, then gradually increased to 21.1% at the 24th postinsertion cycle. Menstrual flow was significantly prolonged only in the T group. This study indicated that blood loss, incidence of menorrhagia, and iron deficiency anemia were lower among Steel Ring users than among VCu 200 and TCu 220c users.
 ...
PMID:Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs. 382 74

The mechanism by which anaemia develops in pregnancy is well understood: haemodilution causes a fall in the haemoglobin concentration during the first and second trimesters of normal pregnancies. Negative iron balance throughout pregnancy, particularly in the latter half, may lead to iron deficiency anaemia during the third trimester. The increase in iron demand is required to meet the expansion in maternal haemoglobin mass and to meet the needs of fetal growth. Fetal demand for iron results in a unidirectional flow of iron to the fetus against a concentration gradient regulated by fetal requirements for iron; this iron transfer occurs almost entirely irrespective of maternal iron status. The development of maternal iron deficiency during pregnancy may be detected by monitoring the haemoglobin concentration frequently; values falling to less than 11 g/dl should be regarded as abnormal, but specific red cell changes, such as microcytosis, may be lacking. A diagnosis of iron deficiency can be most conveniently confirmed by the serum ferritin concentration falling to less than 12 micrograms/l. Women at risk from iron deficiency anaemia can therefore be readily identified and corrective treatment instituted prior to the development of severe anaemia. A serum ferritin concentration of less than 50 micrograms/l in early pregnancy is an indication for iron supplements. Women in whom the serum ferritin concentration is greater than 80 micrograms/l at booking are unlikely to require iron supplements during pregnancy. This approach would eliminate the need for routine prophylactic iron therapy, which, in populations enjoying a good nutritional status, can no longer be justified in early pregnancy. Furthermore, any risk to the fetus from severe maternal anaemia would be avoided by prophylaxis and prompt treatment.
 ...
PMID:Iron metabolism and anaemia in pregnancy. 390 11

To determine if elemental carbonyl iron powder is safe and effective therapy for iron deficiency anemia, 20 nonanemic and 32 anemic volunteers were studied. Single doses of 1,000 to 10,000 mg of carbonyl iron (15 to 150 times the 65 mg of iron in the usual dose of ferrous sulfate) were tolerated by nonanemic volunteers with no evidence of toxicity and only minor gastrointestinal side effects. Anemic volunteers (menstruating women who had previously donated blood) were treated with several regimens providing 1,000 to 3,000 mg of carbonyl iron daily in one to three doses for 8 to 28 days. After 12 weeks anemia was corrected in 29 of 32 patients, and serum ferritin was greater than 12 micrograms/L in 14. Hemoglobin regeneration proceeded at a rate similar to that described for therapy with oral iron salts and parenteral iron dextran. There was no evidence of hematologic, hepatic, or renal toxicity, but mild gastrointestinal side effects occurred in a majority of anemic volunteers. Carbonyl iron is an effective, inexpensive treatment for iron deficiency anemia, is accompanied by tolerable side effects and may have an advantage over therapy with iron salts by substantially reducing or eliminating the risk of iron poisoning in children.
 ...
PMID:Carbonyl iron therapy for iron deficiency anemia. 394 45

Iron status, including S-ferritin, S-iron, S-transferrin, transferrin saturation and haemoglobin, was assessed in 267 selected elderly subjects (128 male, 139 female) with a median age of 79 years (range 60-93 years) not suffering from diseases connected with inappropriately high S-ferritin. In both sexes, S-ferritin levels were practically constant over the examined age range. Males had a geometric mean ferritin of 75 micrograms/l and females a value of 60 micrograms/l (p less than 0.001). Levels of S-ferritin less than 15 micrograms/l (i.e. depleted iron stores) were found in 7.8% of males and in 10.1% of females. An S-ferritin level less than 15 micrograms/l and transferrin saturation less than 15% (i.e. latent iron deficiency) was observed in 2.3% of males and in 2.2% of females. None had iron deficiency anaemia. In subjects (n = 232) without iron deficiency [i.e. S-ferritin greater than or equal to 15 micrograms/l, mean red cell volume greater than or equal to 79 fl and haemoglobin greater than or equal to 121 g/l (7.5 mmol/l)], the arithmetic mean of S-iron was 18 mumol/l. S-transferrin 28 mumol/l and transferrin saturation 33%. The levels of S-iron, S-transferrin and transferrin saturation were not significantly different in males and females.
 ...
PMID:Serum ferritin and iron status in 'healthy' elderly individuals. 395 37

To determine if compromised iron status results from fitness-type exercise, 24 women from a 35-min, 4-day/wk aerobic exercise class provided blood samples at wk 0, 6, and 13. Hb increased from wk 0 to wk 6 (p less than 0.001), and decreased from wk 6 to wk 13 (p less than 0.001). Hematocrit did not change from wk 0 to wk 6, but decreased from wk 6 to wk 13 (p less than 0.005). Ferritin concentrations were lower at wk 6 and 13 (p less than 0.01 and p less than 0.05) than initially. No changes in these measures were detected among 11 sedentary control subjects. Intakes of iron, ascorbic acid, protein, and energy were comparable between exercise and sedentary groups. Decreased resting and recovery step test heart rates indicated improved aerobic fitness in exercising subjects from wk 2 to wk 11. Thirteen weeks of aerobic exercise class did not induce iron deficiency anemia. Decreased plasma ferritin concentrations suggest a compromise in iron stores which appears to be stabilized after 6 wk.
 ...
PMID:The effects of fitness-type exercise on iron status in adult women. 395 83


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>